Mumps

Rate of national measles cases highlights importance of vaccination

Retrieved on: 
Thursday, March 21, 2024

Nationally, the total number of measles cases has already reached the level that occurred during the entire year of 2023.

Key Points: 
  • Nationally, the total number of measles cases has already reached the level that occurred during the entire year of 2023.
  • Infants as young as 6 months can receive the first dose if traveling to areas where the measles infection rate is high.
  • Herd immunity, achieved through a measles vaccination rate of 95% or more, is crucial for preventing disease outbreaks in the community and protecting vulnerable populations who cannot receive vaccines.
  • The measles vaccine, given as part of the MMR (measles, mumps and rubella) vaccine, is extremely effective, giving those vaccinated with just one dose 93% protection against measles infection.

How memes transformed from pics of cute cats to health disinformation super-spreaders

Retrieved on: 
Monday, February 12, 2024

Our research shows that memes form part of a highly sophisticated strategy to spread and monetise health disinformation.

Key Points: 
  • Our research shows that memes form part of a highly sophisticated strategy to spread and monetise health disinformation.
  • Dismissing them as harmless jokes is to grossly underestimate their influence – and bolsters their power to spread potentially harmful health messages.

Anti-vaccine memes have a long history


Memes aren’t a recent invention. They have featured prominently in anti-vaccination messaging for centuries.
When widespread smallpox immunisation began in the early 19th century, political cartoons published in print media used memes (see image below) to evoke fear about the safety of the vaccine.

  • The meme “vaccines cause autism”, which appeared on billboards and was circulated widely in the media, provoked doubts about the safety of the vaccine.
  • The internet enables memes to be created anonymously, repurposed and shared at scale – making them a highly effective medium for spreading health disinformation.
  • Memes play an integral role in disinformation campaigns by facilitating fear, uncertainty and doubt.

Influencers and money

  • Our study analysed how popular anti-vaccine influencers used memes to galvanise the anti-vaccine movement during the COVID pandemic.
  • First, memes were used to vilify the government and social institutions, portraying them as corrupt and politically compromised.
  • Influencers suggested the unvaccinated were being persecuted, using evocative imagery to imply a false equivalence between those who remain unvaccinated by choice and the persecution of Jews during the Holocaust.
  • Vaccination was associated with infertility, low sex drive and a lack of critical thinking.
  • To establish group membership and promote a sense of belonging, influencers referred to those who are anti vaccines as their “soul family”.

Going viral – and avoiding challenge

  • Several influencers provided their followers with “meme drops”: packages of memes with dissemination instructions.
  • These memes were tested and produced in meme factories, then distributed monthly to a mass audience via personal newsletters and websites, encouraging followers to spread anti-vaccination content.
  • By adapting memes to current affairs, influencers increased their relevance and likelihood of going viral.
  • Under the protective guise of humour and satire, memes can evade fact checkers and content moderators while promoting anti-vaccine myths and unauthorised treatments.
  • Memes may not look threatening – but that’s why they are such effective super spreaders of health disinformation.


The authors do not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and have disclosed no relevant affiliations beyond their academic appointment.

DocGo Expands Mobile Health Services with Santa Cruz County, Arizona Department of Health

Retrieved on: 
Tuesday, December 19, 2023

(Nasdaq:DCGO), a leading provider of technology-enabled mobile health services, today announced the expansion of its vaccination and public health initiatives in Arizona through a new contract with the Department of Health in Santa Cruz County, Arizona.

Key Points: 
  • (Nasdaq:DCGO), a leading provider of technology-enabled mobile health services, today announced the expansion of its vaccination and public health initiatives in Arizona through a new contract with the Department of Health in Santa Cruz County, Arizona.
  • Beginning in late November, DocGo now operates a mobile clinic to enhance vaccine accessibility in a rural area with limited access to medical resources.
  • Santa Cruz County is designated as a medically underserved area by the Arizona Department of Health Services.
  • DocGo previously offered flu and COVID vaccines in mobile clinics with Santa Cruz County Health Department, as well as with the Maricopa County Health Department and the state of Arizona Department of Health.

Modine Introduces VidaShield™ UV24 Active Air Disinfection System to K-12 School Markets

Retrieved on: 
Wednesday, December 6, 2023

RACINE, Wis., Dec. 6, 2023 /PRNewswire/ -- Modine (NYSE: MOD), a technology and indoor air quality leader in the HVAC industry, is now offering the VidaShield™ UV24 Active Air Disinfection System product line to the K-12 school market. This innovative solution will further help equip schools with the necessary tools to combat airborne pathogens.

Key Points: 
  • Innovative 24/7 air disinfection system combines germicidal irradiation with air circulation fans to help improve IAQ in schools.
  • RACINE, Wis., Dec. 6, 2023 /PRNewswire/ -- Modine (NYSE: MOD), a technology and indoor air quality leader in the HVAC industry, is now offering the VidaShield™ UV24 Active Air Disinfection System product line to the K-12 school market.
  • VidaShield™ UV24 is a fast, continuous air disinfection system that combines an ultraviolet germicidal irradiation (UVGI) chamber and air circulating fans with an optional overhead ceiling light, making it convenient for schools, universities and daycare centers.
  • For more information about the VidaShield™ UV24 Active Air Disinfection System, please visit https://vidashield.com/ .

Pfizer and BioNTech awarded the 2023 Prix Galien Canada Innovative Product Award

Retrieved on: 
Thursday, November 16, 2023

OTTAWA, ON, Nov. 15, 2023 /CNW/ - Prix Galien Canada is pleased to announce that Pfizer and BioNTech are the recipients of the distinguished Innovative Product Award for their COVID-19 vaccine, Comirnaty.

Key Points: 
  • OTTAWA, ON, Nov. 15, 2023 /CNW/ - Prix Galien Canada is pleased to announce that Pfizer and BioNTech are the recipients of the distinguished Innovative Product Award for their COVID-19 vaccine, Comirnaty.
  • The COVID-19 global pandemic caused severe social and economic disruptions, which meant urgent action was needed to contain its impact.
  • "It is with great pleasure and profound gratitude that I stand here today to accept the prestigious Prix Galien Innovative Product Award on behalf of Pfizer and BioNTech for Comirnaty, Canada's first approved COVID-19 vaccine," said Najah Sampson, President of Pfizer Canada, during the Health Research Foundation Awards Reception in Montreal.
  • For more information on the Innovative Product Award, visit: https://innovativemedicines.ca/prix-galien/

Bioxytran Gets Broad Patent Coverage on 60+ Viruses

Retrieved on: 
Tuesday, October 24, 2023

BOSTON, MASSACHUSETTS, Oct. 24, 2023 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (BIXT), (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat COVID-19 and other viral diseases, announced that the U.S Patent and Trademark Office (USPTO) has published the Company’s patent application WO2023178228A1 Lectin-binding carbohydrates for treating viral infections. The pending patent covers broad claims about the use of hundreds of combinations of antiviral complex carbohydrate drugs to treat over 60 named viruses.

Key Points: 
  • The pending patent covers broad claims about the use of hundreds of combinations of antiviral complex carbohydrate drugs to treat over 60 named viruses.
  • This patent represents what we believe is a new direction in the evolution of antiviral therapies that originally started during the HIV epidemic.
  • This pending patent with its broad claims also shows the Company is well-positioned with respect to its intellectual property portfolio.
  • This patent covers some of the largest indications in virology and includes viruses like COVID-19, influenza, herpes, Epstein-Barr, shingles, hepatitis C, measles, mumps, and rubella.

World Emerging Infectious Disease Diagnostics Market Research Report 2023: Respiratory Infections Take Center Stage in Infectious Disease Diagnostics Post-COVID-19 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 25, 2023

The emergence of the COVID-19 pandemic has had a profound and far-reaching impact on infectious disease diagnostics worldwide.

Key Points: 
  • The emergence of the COVID-19 pandemic has had a profound and far-reaching impact on infectious disease diagnostics worldwide.
  • North America, encompassing both the United States and Canada, currently holds the largest share in the global emerging infectious disease diagnostics market.
  • Some of the common bacterial infections include respiratory infections such as tuberculosis and streptococcal infections and sexually transmitted infections (STIs) such as chlamydia, gonorrhea, and syphilis.
  • Hospitals and clinics play a critical role in the field of infectious disease diagnostics, serving as important centers for patient evaluation and testing.

Global Vaccine Market Anticipated to Reach $92.32 Billion by 2028: Players Include GlaxoSmithKline, AstraZeneca, Sanofi Pasteur, Pfizer and CSL - ResearchAndMarkets.com

Retrieved on: 
Friday, September 8, 2023

Influenza vaccines reduce the risk of illness by 40% to 60% worldwide, including in the United States.

Key Points: 
  • Influenza vaccines reduce the risk of illness by 40% to 60% worldwide, including in the United States.
  • Emerging markets are witnessing a surge in demand for influenza vaccines due to high disease prevalence and limited access to vaccination.
  • Combo Vaccines: Combination vaccines that provide protection against multiple diseases with a single shot are gaining popularity.
  • Government initiatives, growing awareness of the benefits of vaccination, and advancements in vaccine technology have fueled their growth.

Trethera Receives NIH Grant for Preclinical Development in the Pediatric Neurologic Disease Acute Disseminated Encephalomyelitis

Retrieved on: 
Monday, August 14, 2023

Trethera’s first-in-class small molecule, TRE-515, holds the only FDA Orphan Drug designation for Acute Disseminated Encephalomyelitis (ADEM), an acute neurologic disease principally of children.

Key Points: 
  • Trethera’s first-in-class small molecule, TRE-515, holds the only FDA Orphan Drug designation for Acute Disseminated Encephalomyelitis (ADEM), an acute neurologic disease principally of children.
  • ADEM is an autoimmune disease that can present with fever and difficulty walking as well as loss of consciousness and coma.
  • The grant will advance IND enabling studies for a disease where no approved therapies currently exist.
  • Furthermore, should the FDA approve TRE-515 for commercial use in ADEM, Trethera would be eligible for a pediatric priority review voucher.

Measles: it's not just London that's at risk of an outbreak – it's all of the UK

Retrieved on: 
Thursday, July 27, 2023

The UK lost its measles-free status in 2019, indicating that the measles virus was circulating and there was inadequate vaccination to prevent its spread.

Key Points: 
  • The UK lost its measles-free status in 2019, indicating that the measles virus was circulating and there was inadequate vaccination to prevent its spread.
  • The virus spreads like wildfire among the unvaccinated, as demonstrated recently when seven unvaccinated children at a nursery school in Stoke-on-Trent nursery caught the bug.
  • There are no specific drugs for measles, so treatment is to help relieve symptoms and address complications, such as bacterial infections.
  • This pattern is seen globally, with many countries yet to attain the levels of routine immunisation coverage they had pre-pandemic.
  • For MMR, a national catch-up campaign is under way, and many regions have set up measles-elimination groups.
  • If this work is successful, hopefully the UK will be able to regain its measles-free status.